New agents in the management of type 2 diabetes: do they provide an opportunity for a shift in the treatment paradigm?
Valdez
Connie A
CA
Department of ClinicalPharmacy, School of Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA. connie.valdez@uchsc.edu
D000818:Animals; D003365:Costs and Cost Analysis; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology / Q000503:physiopathology; D017850:Economics, Pharmaceutical; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D014481:United States / Q000453:epidemiology
D007004:Hypoglycemic Agents